Total Payments
$25,881
2024 Payments
$3,302
Companies
93
Transactions
1,234
Medicare Patients
5,992
Medicare Billing
$393,799
Payment Breakdown by Category
Food & Beverage$24,124 (93.2%)
Education$1,757 (6.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,124 | 1,200 | 93.2% |
| Education | $1,757 | 34 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,643 | 131 | $0 (2024) |
| Celgene Corporation | $1,712 | 81 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,387 | 71 | $0 (2024) |
| PFIZER INC. | $1,292 | 94 | $0 (2024) |
| Amgen Inc. | $1,283 | 53 | $0 (2023) |
| Incyte Corporation | $1,182 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $998.50 | 53 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $889.06 | 78 | $0 (2024) |
| Astellas Pharma US Inc | $865.47 | 26 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $756.50 | 38 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,302 | 130 | Novartis Pharmaceuticals Corporation ($370.46) |
| 2023 | $4,769 | 197 | Novartis Pharmaceuticals Corporation ($454.01) |
| 2022 | $4,119 | 205 | Novartis Pharmaceuticals Corporation ($394.38) |
| 2021 | $3,456 | 168 | Novartis Pharmaceuticals Corporation ($240.99) |
| 2020 | $2,846 | 144 | Novartis Pharmaceuticals Corporation ($248.14) |
| 2019 | $2,979 | 147 | Celgene Corporation ($316.58) |
| 2018 | $2,470 | 122 | Amgen Inc. ($395.67) |
| 2017 | $1,940 | 121 | Novartis Pharmaceuticals Corporation ($308.10) |
All Payment Transactions
1,234 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $74.99 | General |
| 12/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $34.51 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $35.45 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $27.41 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $1.66 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.06 | General |
| 12/04/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: NONE | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $38.88 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Oncology | ||||||
| 11/08/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $32.72 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Oncology | ||||||
| 10/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $46.75 | General |
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 623 | 3,073 | $197,415 | $78,883 |
| 2022 | 21 | 908 | 3,816 | $237,045 | $89,151 |
| 2021 | 29 | 2,546 | 5,575 | $281,632 | $122,079 |
| 2020 | 30 | 1,915 | 5,099 | $279,976 | $103,686 |
Total Patients
5,992
Total Services
17,563
Medicare Billing
$393,799
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 329 | $89,151 | $34,520 | 38.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 75 | $23,018 | $9,161 | 39.8% |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 2023 | 14 | 73 | $10,220 | $5,978 | 58.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 74 | $11,065 | $4,890 | 44.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 45 | $9,572 | $4,106 | 42.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 28 | $10,152 | $4,042 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 57 | $11,020 | $3,217 | 29.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 38 | $7,519 | $2,149 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 114 | 273 | $3,474 | $2,069 | 59.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 30 | $4,516 | $1,806 | 40.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 18 | $4,673 | $1,774 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,208 | $1,424 | 33.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 12 | 50 | $3,321 | $1,314 | 39.6% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 12 | 47 | $2,876 | $1,203 | 41.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 48 | 84 | $1,179 | $639.24 | 54.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 27 | 41 | $861.00 | $424.35 | 49.3% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 13 | 1,000 | $342.22 | $71.87 | 21.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 770 | $184.80 | $69.64 | 37.7% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 14 | 29 | $62.42 | $24.17 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 312 | $88,870 | $31,409 | 35.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 23 | 75 | $24,333 | $9,733 | 40.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 56 | 137 | $20,956 | $8,217 | 39.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 46 | $19,504 | $7,817 | 40.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 65 | $14,421 | $5,716 | 39.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 39 | 54 | $10,803 | $3,391 | 31.4% |
About Dr. Jack Freimann, M.D
Dr. Jack Freimann, M.D is a Specialist healthcare provider based in Whittier, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306953021.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Freimann, M.D has received a total of $25,881 in payments from pharmaceutical and medical device companies, with $3,302 received in 2024. These payments were reported across 1,234 transactions from 93 companies. The most common payment nature is "Food and Beverage" ($24,124).
As a Medicare-enrolled provider, Freimann has provided services to 5,992 Medicare beneficiaries, totaling 17,563 services with total Medicare billing of $393,799. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location Whittier, CA
- Active Since 08/25/2006
- Last Updated 07/24/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1306953021
Products in Payments
- KEYTRUDA (Biological) $1,335
- KISQALI (Drug) $958.55
- Revlimid (Drug) $865.14
- IMBRUVICA (Drug) $671.33
- XTANDI (Drug) $631.76
- OPDIVO (Biological) $606.69
- Lenvima (Drug) $551.99
- Nplate (Biological) $510.36
- NINLARO (Drug) $464.16
- GILOTRIF (Drug) $443.13
- INLYTA (Drug) $414.69
- MONJUVI (Drug) $408.98
- JAKAFI (Drug) $378.25
- XPOVIO (Drug) $357.81
- PROMACTA (Drug) $332.13
- REBLOZYL (Biological) $327.46
- CABOMETYX (Drug) $325.56
- Pomalyst (Drug) $322.68
- JEVTANA (Drug) $311.86
- ZEJULA (Drug) $298.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Whittier
Dr. Robert Mecum, M.d, M.D
Specialist — Payments: $5,731
Specialist $5,731
Dr. Virginia Lee, M.d, M.D
Specialist — Payments: $5,712
Specialist $5,712
Sudhaker Nayak, M.d, M.D
Specialist — Payments: $3,395
Specialist $3,395
Dr. Ausim Khan, M.d, M.D
Specialist — Payments: $1,668
Specialist $1,668
Dr. David Anderson, M.d, M.D
Specialist — Payments: $311.12
Specialist $311.12
Dr. Marc Mintz, Do, DO
Specialist — Payments: $207.92
Specialist $207.92